MAPT and Alzheimer disease: Moreover, a study utilizing a nanochaperone-mediated autophagy approach showed that targeting pathogenic tau with customized nanochaperones can enhance autophagic flux and clear tau aggregates, significantly alleviating tau burden and cognitive deficits in AD mouse models [158].